LipoScience plunges on CEO exit, revenue guidance

LipoScience (LPDX -10.7%) plummets as CEO Richard Brajer steps down "to pursue other interests."

Robert Greczyn is named interim CEO.

The company says Q2 revenues will likely come in at $13.3M, towards the low end of guidance. Consensus is $13.6M

For the full year, the company cuts its revenue guidance to $52-54M, down from $54-56M, and below Street estimates of $55.37M. (PR)

From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs